Genelux Corp. (GNLX)
4.175
+0.08
(+1.83%)
USD |
NASDAQ |
Dec 17, 16:00
4.175
0.00 (0.00%)
After-Hours: 20:00
Genelux EPS Diluted (Quarterly): -0.2098 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.95M |
| Total Expenses (Quarterly) | 7.95M |
| Enterprise Value | 136.72M |
| Earnings Yield | -21.06% |
| Normalized Earnings Yield | -21.24 |